Telenzepine | CAS#80880-90-6

MedKoo Cat#: 525810 | Name: Telenzepine

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Telenzepine is a potent and selective M1 antimuscarinic.

Chemical Structure

Telenzepine

CAS#80880-90-6

Theoretical Analysis

MedKoo Cat#: 525810

Name: Telenzepine

CAS#: 80880-90-6

Chemical Formula: C19H23N4O2S

Exact Mass: 371.1542

Molecular Weight: 371.48

Elemental Analysis: C, 61.43; H, 6.24; N, 15.08; O, 8.61; S, 8.63

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.

Bulk Inquiry

Related CAS #

No Data

Synonym

Telenzepine

IUPAC/Chemical Name

1-Methyl-10-[2-(4-methylpiperazin-1-yl)acetyl]-5H-thieno[3,4-b][1,5]benzodiazepin-4-one

InChi Key

BXHZKVRXYHIODI-UHFFFAOYSA-N

InChi Code

InChI=1S/C19H23N4O2S/c1-13-18-16(12-26-13)23(25)15-6-4-3-5-14(15)20-19(18)17(24)11-22-9-7-21(2)8-10-22/h3,5,12H,4,6-11H2,1-2H3

SMILES Code

O=[N]1C2=CSC(C)=C2C(C(CN3CCN(C)CC3)=O)=NC4=C1CCC=C4

Appearance

Solid powder

Purity

>98% (or refer to the Certificate of Analysis)

Shipping Condition

Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition

Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility

Soluble in DMSO

Shelf Life

>2 years if stored properly

Drug Formulation

This drug may be formulated in DMSO

Stock Solution Storage

0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code

2934.99.9001

More Info

Instruction

View handling instruction

Preparing Stock Solutions

The following data is based on the product molecular weight 371.48 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Concentration / Solvent Volume / Mass	1 mg	5 mg	10 mg
1 mM	1.15 mL	5.76 mL	11.51 mL
5 mM	0.23 mL	1.15 mL	2.3 mL
10 mM	0.12 mL	0.58 mL	1.15 mL
50 mM	0.02 mL	0.12 mL	0.23 mL

1: Pelosi A, Menardy F, Popa D, Girault JA, Hervé D. Heterozygous Gnal mice are a novel animal model to study dystonia pathophysiology. J Neurosci. 2017 May 25. pii: 1529-16. doi: 10.1523/JNEUROSCI.1529-16.2017. [Epub ahead of print] PubMed PMID: 28546310. 2: Joseph L, Thomsen M. Effects of muscarinic receptor antagonists on cocaine discrimination in wild-type mice and in muscarinic receptor M(1), M(2), and M(4) receptor knockout mice. Behav Brain Res. 2017 Apr 22;329:75-83. doi: 10.1016/j.bbr.2017.04.023. [Epub ahead of print] PubMed PMID: 28442355. 3: Ztaou S, Maurice N, Camon J, Guiraudie-Capraz G, Kerkerian-Le Goff L, Beurrier C, Liberge M, Amalric M. Involvement of Striatal Cholinergic Interneurons and M1 and M4 Muscarinic Receptors in Motor Symptoms of Parkinson's Disease. J Neurosci. 2016 Aug 31;36(35):9161-72. doi: 10.1523/JNEUROSCI.0873-16.2016. PubMed PMID: 27581457. 4: Pediani JD, Ward RJ, Godin AG, Marsango S, Milligan G. Dynamic Regulation of Quaternary Organization of the M1 Muscarinic Receptor by Subtype-selective Antagonist Drugs. J Biol Chem. 2016 Jun 17;291(25):13132-46. doi: 10.1074/jbc.M115.712562. Epub 2016 Apr 14. PubMed PMID: 27080256; PubMed Central PMCID: PMC4933229. 5: Testa B, Vistoli G, Pedretti A. Mechanisms and pharmaceutical consequences of processes of stereoisomerisation - A didactic excursion. Eur J Pharm Sci. 2016 Jun 10;88:101-23. doi: 10.1016/j.ejps.2016.04.007. Epub 2016 Apr 8. Review. PubMed PMID: 27063327. 6: Higashino K, Ago Y, Umeki T, Hasebe S, Onaka Y, Hashimoto H, Takuma K, Matsuda T. Rivastigmine improves isolation rearing-induced prepulse inhibition deficits via muscarinic acetylcholine receptors in mice. Psychopharmacology (Berl). 2016 Feb;233(3):521-8. doi: 10.1007/s00213-015-4123-7. Epub 2015 Oct 31. PubMed PMID: 26518025. 7: Kita Y, Ago Y, Higashino K, Asada K, Takano E, Takuma K, Matsuda T. Galantamine promotes adult hippocampal neurogenesis via M₁ muscarinic and α7 nicotinic receptors in mice. Int J Neuropsychopharmacol. 2014 Dec;17(12):1957-68. doi: 10.1017/S1461145714000613. Epub 2014 May 12. PubMed PMID: 24818616. 8: Young MB, Thomas SA. M1-muscarinic receptors promote fear memory consolidation via phospholipase C and the M-current. J Neurosci. 2014 Jan 29;34(5):1570-8. doi: 10.1523/JNEUROSCI.1040-13.2014. PubMed PMID: 24478341; PubMed Central PMCID: PMC3905134. 9: Jin S, Sarkar KS, Jin YN, Liu Y, Kokel D, Van Ham TJ, Roberts LD, Gerszten RE, Macrae CA, Peterson RT. An in vivo zebrafish screen identifies organophosphate antidotes with diverse mechanisms of action. J Biomol Screen. 2013 Jan;18(1):108-15. doi: 10.1177/1087057112458153. Epub 2012 Sep 6. PubMed PMID: 22960781; PubMed Central PMCID: PMC4053346. 10: Kita Y, Ago Y, Takano E, Fukada A, Takuma K, Matsuda T. Galantamine increases hippocampal insulin-like growth factor 2 expression via α7 nicotinic acetylcholine receptors in mice. Psychopharmacology (Berl). 2013 Feb;225(3):543-51. doi: 10.1007/s00213-012-2841-7. Epub 2012 Aug 30. PubMed PMID: 22932776. 11: Savelkoul PJ, Janickova H, Kuipers AA, Hageman RJ, Kamphuis PJ, Dolezal V, Broersen LM. A specific multi-nutrient formulation enhances M1 muscarinic acetylcholine receptor responses in vitro. J Neurochem. 2012 Feb;120(4):631-40. doi: 10.1111/j.1471-4159.2011.07616.x. Epub 2012 Jan 6. PubMed PMID: 22146060. 12: Motta PG, Perez AC, Alves DP, Duarte ID. Modulation of peripheral inflammatory pain thresholds by M(1) and nicotinic receptor antagonists. Pharmacology. 2011;88(5-6):309-15. doi: 10.1159/000333791. Epub 2011 Nov 19. PubMed PMID: 22104294. 13: Profita M, Bonanno A, Montalbano AM, Ferraro M, Siena L, Bruno A, Girbino S, Albano GD, Casarosa P, Pieper MP, Gjomarkaj M. Cigarette smoke extract activates human bronchial epithelial cells affecting non-neuronal cholinergic system signalling in vitro. Life Sci. 2011 Jul 4;89(1-2):36-43. doi: 10.1016/j.lfs.2011.04.025. Epub 2011 May 18. PubMed PMID: 21620875. 14: Blomeley CP, Cains S, Smith R, Bracci E. Ethanol affects striatal interneurons directly and projection neurons through a reduction in cholinergic tone. Neuropsychopharmacology. 2011 Apr;36(5):1033-46. doi: 10.1038/npp.2010.241. Epub 2011 Feb 2. PubMed PMID: 21289603; PubMed Central PMCID: PMC3077272. 15: Inan S, Dun NJ, Cowan A. Investigation of gastrin-releasing peptide as a mediator for 5'-guanidinonaltrindole-induced compulsive scratching in mice. Peptides. 2011 Feb;32(2):286-92. doi: 10.1016/j.peptides.2010.11.022. Epub 2010 Nov 30. PubMed PMID: 21126550; PubMed Central PMCID: PMC3995915. 16: Koda K, Ago Y, Yano K, Nishimura M, Kobayashi H, Fukada A, Takuma K, Matsuda T. Involvement of decreased muscarinic receptor function in prepulse inhibition deficits in mice reared in social isolation. Br J Pharmacol. 2011 Feb;162(3):763-72. doi: 10.1111/j.1476-5381.2010.01080.x. PubMed PMID: 20958289; PubMed Central PMCID: PMC3041263. 17: Ago Y. [Beneficial effect of galantamine on sensory information-processing deficits]. Yakugaku Zasshi. 2010 Oct;130(10):1305-10. Review. Japanese. PubMed PMID: 20930482. 18: Hern JA, Baig AH, Mashanov GI, Birdsall B, Corrie JE, Lazareno S, Molloy JE, Birdsall NJ. Formation and dissociation of M1 muscarinic receptor dimers seen by total internal reflection fluorescence imaging of single molecules. Proc Natl Acad Sci U S A. 2010 Feb 9;107(6):2693-8. doi: 10.1073/pnas.0907915107. Epub 2010 Jan 20. PubMed PMID: 20133736; PubMed Central PMCID: PMC2823895. 19: Li Z, Prus AJ, Dai J, Meltzer HY. Differential effects of M1 and 5-hydroxytryptamine1A receptors on atypical antipsychotic drug-induced dopamine efflux in the medial prefrontal cortex. J Pharmacol Exp Ther. 2009 Sep;330(3):948-55. doi: 10.1124/jpet.109.155663. Epub 2009 Jun 2. PubMed PMID: 19491322. 20: Bozkurt TE, Sahin-Erdemli I. M(1) and M(3) muscarinic receptors are involved in the release of urinary bladder-derived relaxant factor. Pharmacol Res. 2009 May;59(5):300-5. doi: 10.1016/j.phrs.2009.01.013. Epub 2009 Feb 5. PubMed PMID: 19416629.